Phase Ib and Expansion Study of Gemcitabine, Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer

Perez, K., Chiarella, A. M., Cleary, J. M., Horick, N., Weekes, C., Abrams, T., Blaszkowsky, L., Enzinger, P., Giannakis, M., Goyal, L., Meyerhardt, J. A., Rubinson, D., Yurgelun, M. B., Goessling, W., Giantonio, B. J., Brais, L., Germon, V., Stonely, D., Raghavan, S., … Wolpin, B. M. (2023). Phase Ib and Expansion Study of Gemcitabine,Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer. The Oncologist, 28(5), 425–432. https://doi.org/10.1093/oncolo/oyad002
Authors:
Kimberly Perez
Anna M Chiarella
James M Cleary
Nora Horick
Colin Weekes
Thomas Abrams
Lawrence Blaszkowsky
Peter Enzinger
Marios Giannakis
Lipika Goyal
Jeffrey A Meyerhardt
Douglas Rubinson
Matthew B Yurgelun
Wolfram Goessling
Bruce J Giantonio
Lauren Brais
Victoria Germon
Danielle Stonely
Srivatsan Raghavan
Basil Bakir
Koushik Das
Jason R Pitarresi
Andrew J Aguirre
Michael Needle
Anil K Rustgi
Brian M Wolpin
Affiliated Authors:
Anna M Chiarella
Basil Bakir
Anil K Rustgi
Columbia Affiliation:
Subjects:
Pancreatic Cancer Research and Treatment (OpenAlex Topic)
Mechanisms and Treatment of Liver Fibrosis (OpenAlex Topic)
Epidemiology and Management of Neuroendocrine Tumors (OpenAlex Topic)
Hypoalbuminemia (MeSH)
Pancreatic Neoplasms (MeSH)
Author Keywords:
ficlatuzumab
gemcitabine
metastatic pancreatic cancer
nab-paclitaxel
phase ib clinical trial
elink
Publication Type:
Article
Unique ID:
10.1093/oncolo/oyad002
PMID:
36807743
DOI:
10.1093/oncolo/oyad002
Journal:
Oncologist
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View OpenAlex Record

Record Created: